The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents
Lena Xiao
82 participants
Jun 12, 2025
OBSERVATIONAL
Conditions
Summary
Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep. Studying how insomnia affects PAP adherence in children can help improve future treatments. However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.
Eligibility
Inclusion Criteria3
- Children aged 8-18 years old
- Obstructive apnea-hypopnea index ≥ 5/hour on baseline diagnostic polysomnogram (PSG)
- Newly prescribed PAP therapy
Exclusion Criteria1
- \) Developmental disability precluding ability to answer questionnaires
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Initiation of continuous or bilevel positive airway pressure therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07176767